HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sumit Randhir Singh Selected Research

Macular Edema

6/2019Long-term outcomes after intravitreal dexamethasone treatment in steroid responders.
1/2019Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion.
11/2017Intravitreal Ziv-Aflibercept: Clinical Effects and Economic Impact.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sumit Randhir Singh Research Topics

Disease

13Macular Degeneration (Age-Related Maculopathy)
12/2023 - 11/2017
8Central Serous Chorioretinopathy
02/2024 - 01/2020
4Atrophy
02/2024 - 11/2020
4Retinal Detachment (Retinal Detachments)
01/2019 - 01/2018
3Diabetic Retinopathy (Retinopathy, Diabetic)
07/2022 - 01/2020
3Choroidal Neovascularization
03/2021 - 07/2018
3Macular Edema
06/2019 - 11/2017
2Vitreous Detachment (Posterior Vitreous Detachment)
07/2023 - 01/2018
2Blindness (Hysterical Blindness)
05/2022 - 07/2020
2Geographic Atrophy
05/2022 - 05/2019
2Polypoidal Choroidal Vasculopathy
09/2020 - 01/2019
2Hemorrhage
07/2020 - 07/2018
2Retinal Vein Occlusion
01/2019 - 11/2017
1Epiretinal Membrane (Epiretinal Membranes)
07/2023
1Wounds and Injuries (Trauma)
07/2023
1Retinal Perforations
07/2023
1Inflammation (Inflammations)
03/2023
1Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
03/2023
1Choroid Diseases
08/2022
1Retinal Diseases
07/2021
1Eye Diseases (Eye Disease)
01/2021
1Polyps
09/2020
1Cushing Syndrome
01/2020
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2020
1Vitreous Hemorrhage
01/2020
1Ocular Hypertension (Glaucoma, Suspect)
06/2019
1Hamartoma
01/2019
1Endophthalmitis (Ophthalmia)
01/2018
1Choroidal Effusions
01/2018
1Glaucoma
01/2018
1Blister (Bulla)
01/2018

Drug/Important Bio-Agent (IBA)

12Retinaldehyde (Retinal)IBA
08/2022 - 01/2018
6Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2020
6afliberceptIBA
10/2020 - 11/2017
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2024 - 06/2019
3Fluorescein (Funduscein)FDA LinkGeneric
04/2021 - 07/2018
3Bevacizumab (Avastin)FDA Link
10/2020 - 01/2019
3Silicone OilsIBA
01/2019 - 01/2018
3perflutren (octafluoropropane)FDA Link
01/2019 - 01/2018
2Retinal Pigments (Pigments, Visual)IBA
07/2023 - 03/2023
1TamoxifenFDA LinkGeneric
07/2023
1VitaminsIBA
01/2021
1Drinking WaterIBA
01/2021
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
09/2020
11-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2020
1SteroidsIBA
06/2019
1Dexamethasone (Maxidex)FDA LinkGeneric
06/2019
1brilliant blue (brilliant blue FCF)IBA
05/2019
1Antifibrotic AgentsIBA
01/2018

Therapy/Procedure

5Therapeutics
12/2023 - 06/2019
2Lasers (Laser)
07/2023 - 06/2020
2Photochemotherapy (Photodynamic Therapy)
09/2020 - 06/2020
1Injections
02/2024
1Traction
07/2023
1Vitrectomy
01/2018
1Decompression
01/2018